Company news

Poolbeg Pharma PLC news in 2026

Poolbeg Pharma PLC's news releases, calls and decks from 2026, newest first.

View company

POLB001 CRS Patent Granted in South Korea

October 6, 2026

Interim Results for the six months to 30 June 2026

September 29, 2026

POLB 001 TOPICAL trial recruitment update

September 28, 2026

Interim data from POLB 001 TOPICAL clinical trial

September 24, 2026

Key Conference Participation in September 2026

September 3, 2026

Notification of major holdings

July 23, 2026

Notice of Allowance for POLB 001 patent in Israel

July 21, 2026

Placing to raise £3.5 million

July 14, 2026

First patient dosed in POLB 001 TOPICAL trial

July 13, 2026

POLB 001 patent granted in South Africa

June 30, 2026

European patent granted for POLB 001 in CRS

June 16, 2026

Preclinical data posters presented at EHA Congress

June 11, 2026

Results of AGM & Change of Registered Address

June 9, 2026

Pre-IND Meeting with the FDA for POLB 001

May 26, 2026

POLB 001 poster to be presented at EHA 2026

May 13, 2026

POLB 001 CRS patent granted in Canada

May 11, 2026

Results for the year ended 31 December 2025

April 28, 2026

MHRA grants CTA for the POLB 001 TOPICAL trial

April 15, 2026

Significant milestone for Poolbeg's IP portfolio

March 31, 2026

Appointment of Dr Adrian Kilcoyne to SAB

March 12, 2026

Notification of Major Holdings

February 9, 2026

POLB 001 LPS Challenge Trial Paper Published

January 28, 2026

Exercise of Options & Total Voting Rights

January 27, 2026

Calls in 2026

Decks in 2026